From: The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma
Clinicopathological features
Multivariate logistic regression
HR
95% CI
P
Pathological grade (G3 vs. G2/G1)
2.460
0.437–13.860
0.307
Enneking stage (III vs. IIA/IIB)
3.991
1.110–14.346
0.034
PSMD14 expression (high vs. low)
3.632
1.134–11.635
0.030